The program is designed to prepare state-licensed pharmacists to meet requirements for administering vaccinations to pediatric patients.
Pediatric vaccine
Two pharmacy organizations are partnering to offer a new education program to prepare state-state-licensed immunizing pharmacists to meet the requirements to administer vaccinations to children, in compliance with new guidelines issued by the U.S. Department of Health and Human Services (HHS).1
The American Pharmacists Association (APhA), in partnership with Washington State University College of Pharmacy and Pharmaceutical Sciences, launched Pharmacy-based Immunizations for Pediatric Patients.2
The program provides a thorough review of topics related to immunizing pediatric patients, including parent and patient preparation, immunization administration techniques for children, and documentation of pediatric vaccinations, APhA said in a news release.3
“When the new HHS guidelines were announced, we moved quickly to put this program in place for our members. Including pharmacists as immunizers is critical to preventing the spread of flu this season and ensuring that all patients have convenient access to the COVID-19 vaccine when one is available,” said APhA Executive Vice President and CEO Scott J. Knoer, MS, PharmD, FASHP.
Upon completion of the program, pharmacists will be able to:2
More than 375,000 pharmacists have completed APhA’s Pharmacy-Based Immunization Delivery Certificate Training Program, which meets the practical training required by the Accreditation Council for Pharmacy Education (ACPE), APhA said.
The new program meets the minimum of 2 hours of ACPE-approved, immunization-related continuing pharmacy education during each state licensing period.
With this new HHS guidance, pharmacists can further demonstrate their ability to provide important health care services like immunizations, which improve public health outcomes. “We created this program, along with many other COVID-19 related resources from APhA, to give pharmacists the tools they need to succeed,” Knoer said.
References:
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years
April 9th 2024Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.